Biomarker bonanza?
Publication
, Journal Article
Califf, RM; Shah, SH; Newby, LK
Published in: J Am Coll Cardiol
March 23, 2010
Duke Scholars
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
March 23, 2010
Volume
55
Issue
12
Start / End Page
1197 / 1199
Location
United States
Related Subject Headings
- Risk Factors
- Ranolazine
- Piperazines
- Natriuretic Peptide, Brain
- Humans
- Enzyme Inhibitors
- Cardiovascular System & Hematology
- Biomarkers
- Acute Coronary Syndrome
- Acetanilides
Citation
APA
Chicago
ICMJE
MLA
NLM
Califf, R. M., Shah, S. H., & Newby, L. K. (2010). Biomarker bonanza? J Am Coll Cardiol, 55(12), 1197–1199. https://doi.org/10.1016/j.jacc.2009.10.051
Califf, Robert M., Svati H. Shah, and L Kristin Newby. “Biomarker bonanza?” J Am Coll Cardiol 55, no. 12 (March 23, 2010): 1197–99. https://doi.org/10.1016/j.jacc.2009.10.051.
Califf RM, Shah SH, Newby LK. Biomarker bonanza? J Am Coll Cardiol. 2010 Mar 23;55(12):1197–9.
Califf, Robert M., et al. “Biomarker bonanza?” J Am Coll Cardiol, vol. 55, no. 12, Mar. 2010, pp. 1197–99. Pubmed, doi:10.1016/j.jacc.2009.10.051.
Califf RM, Shah SH, Newby LK. Biomarker bonanza? J Am Coll Cardiol. 2010 Mar 23;55(12):1197–1199.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
March 23, 2010
Volume
55
Issue
12
Start / End Page
1197 / 1199
Location
United States
Related Subject Headings
- Risk Factors
- Ranolazine
- Piperazines
- Natriuretic Peptide, Brain
- Humans
- Enzyme Inhibitors
- Cardiovascular System & Hematology
- Biomarkers
- Acute Coronary Syndrome
- Acetanilides